Stocks and InvestingStocks and Investing
Thu, June 9, 2022
Wed, June 8, 2022
Tue, June 7, 2022
Mon, June 6, 2022
Sun, June 5, 2022
Fri, June 3, 2022

Justin Zelin Maintained (CASI) at Strong Buy with Increased Target to $21 on, Jun 3rd, 2022


Published on 2024-10-27 21:24:57 - WOPRAI, Justin Zelin
  Print publication without navigation


Justin Zelin of BTIG, Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Increased Target from $4 to $21 on, Jun 3rd, 2022.

Justin has made no other calls on CASI in the last 4 months.



There is 1 other peer that has a rating on CASI. Out of the 1 peers that are also analyzing CASI, 0 agree with Justin's Rating of Hold.



This is the rating of the analyst that currently disagrees with Justin


  • Sean Lee of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $30 on, Monday, May 16th, 2022